comparemela.com

Latest Breaking News On - Obseva sa - Page 1 : comparemela.com

Annual General Meeting 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 8, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical.

Plan les ouatesFranche comtérCatarina edfjLuigi marroMerck seronoErnest loumayeEconomical statistic sciencesArticles of associationCompensation committeeMaster of business administrationSwiss exchangeUniversity in lyonObseva executive committeeCommittee for the fiscal yearVoisin life sciences consultingStrategy development

Investegate |ObsEva SA Announcements | ObsEva SA: ObsEva Annual Report 2022

Investegate announcements from ObsEva SA, ObsEva Annual Report 2022

Shauna dillonSwiss exchangeOffice contactObseva annual reportAnnual reportInvestegate announcementsInvestegate company announcementsObseva saLobenewswire and globenewswire

ObsEva Annual Report 2022

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – April 28, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical.

Shauna dillonSwiss exchangeOffice contactAnnual reportNasdaq obsvObseva saAnnual report

Investegate |ObsEva SA Announcements | ObsEva SA: ObsEva Files Year End 2022 Financial Statements

Investegate announcements from ObsEva SA, ObsEva Files Year End 2022 Financial Statements

Shauna dillonSwiss exchangeObseva files year endEva filesyear endFiscal yearSwiss annual reportInvestegate announcementsInvestegate company announcementsObseva saLobenewswire and globenewswire

Investegate |ObsEva SA Announcements | ObsEva SA: ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update

Investegate announcements from ObsEva SA, ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update

Yuyuan bioscienceShauna dillonBrian ocallaghanExchange commissionManagement incKissei pharmaceutical co ltdChinese national medical products administrationSwiss exchangeObseva announces third quarterBriano callaghanBusiness highlightsDrug evaluationChinese national medical productsEbopiprant rightsNasdaq stock marketThird quarter ended september

vimarsana © 2020. All Rights Reserved.